ZK-261991
ZK-261991 is an orally active VEGFR tyrosine kinase inhibitor with an IC50 of 5 nM for VEGFR2.
Product Specifications
CAS Number
886563-25-3
UNSPSC
12352005
Target
VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ZK-261991.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC2=NN(C)C=C2C=C1)C3=CC=CC=C3NCC4=CC(NC(N(C)C)=O)=NC=C4
Molecular Formula
C24H25N7O2
Molecular Weight
443.50
References & Citations
[1]Deniz Hos, et al. Inflammatory Corneal (Lymph) angiogenesis Is Blocked by VEGFR-Tyrosine Kinase Inhibitor ZK 261991, Resulting in Improved Graft Survival after Corneal Transplantation. Investigative Ophthalmology & Visual Science May 2008, Vol.49, 1836-1842.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
VEGFR2/KDR/Flk-1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC403169-500 1x 500 µL
SOX2 (Embryonic Stem Cell Marker) (SOX2/3169R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB0820-100 1x 100 µL
Caldesmon, HMW (h-Caldesmon) (CALD1/820), 0.2mg/mL
Sign In for Pricing
View Details 